Table 1.
Clinical pathological characteristics correlation analysis with MUC1-C expression in a 131 NSCLC cohort
| Characteristics | Total | MUC1-C expression | F/X2 | P-value | ||
|---|---|---|---|---|---|---|
| Negative (%) | Low (%) | High (%) | ||||
| Age (years) | 0.776 | 0.678 | ||||
| < =65 | 105 | 7 (6.7) | 32 (30.5) | 66 (62.9) | ||
| > 65 | 26 | 1 (3.8) | 10 (38.5) | 15 (57.7) | ||
| Gender | 16.215 | < 0.001 | ||||
| Male | 105 | 8 (7.6) | 41 (39.0) | 56 (53.3) | ||
| Female | 26 | 0 (0.0) | 1 (3.8) | 25 (96.2) | ||
| Smoking history | 17.501 | < 0.001 | ||||
| Yes | 90 | 8 (8.9) | 37 (41.1) | 45 (50.0) | ||
| No | 41 | 0 (0.0) | 5 (12.2) | 36 (87.8) | ||
| Pathological pattern | 60.153 | < 0.001 | ||||
| Adenocarcinoma | 74 | 0 (0.0) | 7 (9.5) | 67 (90.5) | ||
| Squamous cell | 57 | 8 (14.0) | 35 (61.4) | 14 (24.6) | ||
| Cell differentiation | 5.542 | 0.236 | ||||
| Poorly | 28 | 1 (3.6) | 12 (42.9) | 15 (53.6) | ||
| Moderately | 93 | 5 (5.4) | 28 (30.1) | 60 (64.5) | ||
| Well | 10 | 2 (20.0) | 2 (20.0) | 6 (60.0) | ||
| TNM stage | 13.306 | 0.038 | ||||
| I | 62 | 4 (6.5) | 18 (29.0) | 40 (64.5) | ||
| II | 37 | 3 (8.1) | 19 (51.4) | 15 (40.5) | ||
| III | 28 | 1 (3.6) | 5 (17.9) | 22 (78.6) | ||
| IV | 4 | 0 (0.0) | 0 (0.0) | 4 (100.0) | ||